A Randomized, Open-label, Crossover Phase 1 Clinical Trial to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety After Single/Multiple Administration of CKD-382, D860 and D027 in Healthy Subjects
Latest Information Update: 05 Oct 2023
At a glance
- Drugs CKD 382 (Primary) ; D 027 (Primary) ; D 860 (Primary)
- Indications Gastro-oesophageal reflux
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Chong Kun Dang
- 09 Nov 2021 New trial record